The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

PURPOSE: The development of blood biomarkers that reflect Alzheimer’s disease (AD) pathophysiology (phosphorylated tau and amyloid-β) has offered potential as scalable tests for dementia differential diagnosis and early detection. In 2019, the Geneva AD Biomarker Roadmap Initiative included blood bi...

全面介紹

Na minha lista:
書目詳細資料
發表在:Eur J Nucl Med Mol Imaging
Main Authors: Ashton, N. J., Leuzy, A., Karikari, T. K., Mattsson-Carlgren, N., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Nordberg, A., Ossenkoppele, R., Zetterberg, H., Blennow, K., Frisoni, G. B., Garibotto, V., Hansson, O.
格式: Artigo
語言:Inglês
出版: Springer Berlin Heidelberg 2021
主題:
Review Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8175325/
https://ncbi.nlm.nih.gov/pubmed/33677733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-021-05253-y
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍